P2RX7 and myeloid sarcoma: In this study, we report that CLM increases the rate of disability accumulation in patients with advanced MS progressing by PIRA, by facilitating prolonged opening of the P2RX7 channel, potentiating intrathecal pyroptosis of myeloid cells and OLGs in MS CNS.